Li-fraumeni Syndrome
📧 Sign up to get email alerts when something new happens for Li-fraumeni Syndrome.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2009-12-19EMA Application withdrawn: Advexin — Gendux Molecular Limited
The EMA status shows the Advexin application has been withdrawn for Li-Fraumeni Syndrome by Gendux Molecular Limited.